Summary
In 12 in-patients with moderate uncomplicated hypertension, maintained on constant sodium intake for 15 days, single-blind oral administration of verapamil 80–160 mg t. i. d. for 10 days had a significant antihypertensive effect: in the supine position systolic blood pressure decreased from 177±5 to 150±3 mmHg, and diastolic pressure from 111±3 to 96±2 mmHg; standing values were similarly lowered from 171±7 to 143±4 mmHg, systolic, and from 118±4 to 97±2 mmHg, diastolic. The heart rate did not show any significant change (from 79±3 to 77±2 beats/min, supine, and from 92±3 to 87±3 beats/min, upright). The antihypertensive effect was uniform throughout the day, being similar 2, 3, 6 and 8 h after administration of a dose. Dynamic exercise (75–100 watts on a cycle-ergometer) caused identical increases in arterial pressure and heart rate on the last day of placebo and again on the last day with verapamil, but the peak levels of systolic pressure reached during exercise were lower after verapamil than with placebo, because of the lower blood pressure before exercise. Reduction of arterial pressure by verapamil was not accompanied by increased plasma renin activity, or by renal retention of sodium and water: there was a small increase in sodium excretion, at least during the first days of verapamil administration (from 107±15 to 113±15 mEq Na+/day), and a slight significant reduction in body weight (from 74.2±3.7 to 73.5±3.7 kg). It is concluded that oral administration of verapamil significantly lowers blood pressure without simultaneously inducing cardiac stimulation, renin secretion or salt and water retention.
Similar content being viewed by others
References
Grün G, Fleckenstein A, Byon KY (1971) Ca-antagonism, a new principle of vasodilation. Proc Inter Union Physiol Sci, XXV, Int Congr Munich IX: 221
Fleckenstein A, Grün G, Byon KY (1975) Gli effetti fondamentali Ca-antagonisti del Verapamil sulle fibre miocardiche e sulle cellule muscolari lisce dei vasi. Minerva Med 66: 1827–1837
Rydén L, Saetre H (1971) The haemodynamic effect of Verapamil. Eur J Clin Pharmacol 3: 153–157
Bender F (1970) Treatment of tachycardic arrhythmias and arterial hypertension with Verapamil. Arzneim Forsch 20: 1310–1316
Diekmann L, Hosermann R (1974) Antihypertensive effect of Verapamil: investigations and experiences in children. Münch Med Wochenschr 116: 515–520
Ross G, Jorgensen CR (1967) Cardiovascular actions of iproveratril. J Pharmacol Exp Ther 158: 504–509
Nayler WG, McInnes I, Swann JB, Prices JM, Carson V, Race D, Lowe TE (1968) Some effects of iproveratril (Isoptin) on the cardiovascular system. J Pharmacol Exp Ther 161: 247–261
Hagino D (1968) Application of iproveratril in the pharmacotherapy of hypertension. Jpn J Clin Exp Med 45: 208–212
Lewis GRJ, Morely KD, Lewis BM, Bones PJ (1978) Verapamil in the arterial hypertension. N Z Med J 87: 351–354
Leary WP, Asmal AC (1979) Treatment of hypertension with Verapamil. Curr Ther Res 25: 747–752
Lederballe Pedersen O (1978) Does Verapamil have a clinically-significant antihypertensive effect? Eur J Clin Pharmacol 13: 21–24
Oblad B (1973) A study of the mechanism of the hemodynamic effects of hydralazine in man. Acta Pharmacol Toxicol 20: Suppl 1: 1–8
Moyer JH (1953) Hydralazine hydrochloride: pharmacological observation and clinical results in the therapy of hypertension. Arch Intern Med 91: 419–429
Bartorelli C, Gargano N, Leonetti G, Zanchetti A (1963) Hypotensive and renal effects of diazoxide, a sodium-retaining benzothiadiazine compound. Circulation 27: 895–903
Pohl JEF, Thurston H, Swales JD (1972) The antidiuretic action of diazoxide. Clin Sci 42: 145–152
Ducharme D, Freyburger W, Graham B, Carlson R (1973) Pharmacological properties of minoxidil: a new hypotensive agent. J Pharmacol Exper Ther 184: 662–670
Pettinger W, Mitchell HC (1975) Renin release, saralasin and the vasodilator beta-blocker drug interaction in man. N Engl J Med 292: 1214–1217
Dustan HP, Tarazi RC, Bravo EL (1975) Hemodynamic adjustments during long-term antihypertensive drug therapy. In: Milliez P, Safar M (eds) Recent advances in hypertension. Boehringer Ingelheim, Reims, pp 247–258
Leonetti G, Bonazzi O, Grazi S, Ligresti A, Romano S, Zanchetti A (1971) Cardiovascular and renal effects of acute administration of a new hypotensive compound: guancydine. Eur J Clin Pharmacol 4: 1–9
Stemberg G, Sannerstedt R, Werkö L (1971) Haemodynamic studies on the antihypertensive effect of guancydine. Eur J Clin Pharmacol 3: 63–67
Report of WHO expert committee (1978) Arterial hypertension. Technical report Series 628. World Health Organization Geneva
Haber E, Hoerner T, Page LB (1969) Application of a radioimmunoassay for Angiotensin I to physiologic measurements of plasma renin activity in normal human plasma. J Clin Endocrinol Metab 29: 1349–1355
Richardson D, Stella A, Leonetti G, Bartorelli A, Zanchetti A (1974) Mechanisms of renal release of renin by electrical stimulation of the brainstem in the cat. Circ Res 34: 425–434
Snedecor GW, Cochran WG (1967) Statistical methods, 6th ed, chap 6 and 11. Iowa State University Press, Ames
Husaini MH, Kvasmcka J, Ryden L, Holmberg S (1973) Action of verapamil on sinus node, atrioventricular and intraventricular conduction. Br Heart J 33: 734–737
Roy PR, Spurrel RA, Sowton E (1974) The effect of verapamil on the conduction system in man. Postgrad Med J 50: 270–276
Rosen MR, Wit AL, Hoffman BF (1975) Electrophysiology and pharmacology of cardiac arrhythmias. VII. Cardiac effects of Verapamil. Am Heart J 89: 665–678
Thirwell MP, Zsoter TT (1972) The effect of diazoxide on the veins. Am Heart J 83: 512–517
Tarazi RC, Dustan HP, Bravo EL Niarchos AP (1976) Vasodilating drugs: contrasting hemodynamic effects. Clin Sci Mol Med 51: 575s-578s
Koch-Weser J (1974) Vasodilating drugs in the treatment of hypertension. Arch Int Med 133: 1017–1021
Bathia S, Frohlich ED (1973) Hemodynamic comparison of agents useful in hypertensive emergencies. Am Heart J 85: 367–373
Costantine JW, McShane WK, Scriabine A, Hess HJ (1973) Analysis of the hypotensive action of prazosin. In: Onesti G, Kim KE, Moyer JH (eds) Hypertension: mechanisms and management. Grune & Stratton, New York, pp 429–444
Mancia G, Ferrari A, Gregorini L, Ferrari MC, Bianchini C, Terzoli L, Leonetti G, Zanchetti A (1979) Regulation of the circulation during antihypertensive treatment with prazosin. In: Rawlings MD, Geyer G, Bleifeld W (eds) Proc. Europ. Prazosin Symp., Vienna 24–25 Nov. 1978. Excerpta Medica, Amsterdam, pp 15–22
Graham RM, Pettinger WA (1979) Prazosin. N Engl J Med 300: 232–236
Bendall MJ, Badoch KH, Wilson PR (1975) Side-effects due to treatment of hypertension with prazosin. Br Med J 2: 727–728
Gabriel R, Meek D, Ghosh BC (1975) Collapse after prazosin hydrochloride. Lancet 1: 1095
Bouillin DJ (1967) The action of extracellular cations on the release of the sympathetic transmitter from peripheral nerves. J Physiol 189: 85–89
Burn JH, Gibbons WR (1965) The release of noradrenaline from sympathetic nerve fibres in relation to calcium concentration. J Physiol 187: 214–223
Wit AL, Cranefield PE (1974) Effect of verapamil on the sinoatrial and atrioventricular nodes of rabbit and mechanism by which it arrests reentrant atrioventricular nodal tachycardia. Circ Res 35: 413–425
Zipes DP, Fischer JC (1974) Effect of agents which inhibit channel of sinus node automaticity and atrioventricular conduction in the dog. Circ Res 34: 184–192
Vandongen R, Peart WS (1974) The inhibition of renin secretion by alpha-adrenergic stimulation in the isolated rat kidney. Clin Sci Mol Med 47: 471–479
Guyton AC, Coleman TG, Cowley A Jr, Scheel KW, Manning E, Norman RA Jr (1972) Arterial pressure regulation. Overriding dominance of kidneys in long-term regulation and in hypertension. Am J Med 52: 584–594
Zanchetti A, Stella A, Baccelli G, Mancia G (1979) Neural influences on kidney function in the pathogenesis of arterial hypertension. In: Onesti G, Klint CR (eds) Hypertension determinants, complications and intervention. Grune & Stratton, New York, pp 99–106
Olivari MT, Bartorelli C, Polese A, Fiorentini C, Moruzzi P, Guazzi M (1979) Treatment of hypertension with nifedipine, a calcium antagonist agent. Circulation 59: 1056–1062
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Leonetti, G., Sala, C., Bianchini, C. et al. Antihypertensive and renal effects of orally administered verapamil. Eur J Clin Pharmacol 18, 375–382 (1980). https://doi.org/10.1007/BF00636788
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00636788